An overview on the treatments and prevention against COVID-19

Y Panahi, AM Gorabi, S Talaei, F Beiraghdar… - Virology Journal, 2023 - Springer
Background The coronavirus disease 2019 (COVID-19) caused by the severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) continues to plague the world. While …

Therapeutic implications of current Janus kinase inhibitors as anti-COVID agents: A review

NK Jain, M Tailang, HK Jain… - Frontiers in …, 2023 - frontiersin.org
Severe cases of COVID-19 are characterized by hyperinflammation induced by cytokine
storm, ARDS leading to multiorgan failure and death. JAK-STAT signaling has been …

[HTML][HTML] Drug repurposing for the treatment of COVID-19: Targeting nafamostat to the lungs by a liposomal delivery system

P Reus, H Guthmann, N Uhlig, M Agbaria… - Journal of Controlled …, 2023 - Elsevier
Despite tremendous global efforts since the beginning of the COVID-19 pandemic, still only
a limited number of prophylactic and therapeutic options are available. Although vaccination …

Clinical significance of carnitine in the treatment of cancer: from traffic to the regulation

R Farahzadi, MS Hejazi, O Molavi… - Oxidative Medicine …, 2023 - Wiley Online Library
Metabolic reprogramming is a common hallmark of cancer cells. Cancer cells exhibit
metabolic flexibility to maintain high proliferation and survival rates. In other words …

Gas6/TAM axis involvement in modulating inflammation and fibrosis in COVID-19 patients

M Rizzi, S Tonello, D D'Onghia… - International Journal of …, 2023 - mdpi.com
Gas6 (growth arrest-specific gene 6) is a widely expressed vitamin K-dependent protein that
is involved in many biological processes such as homeostatic regulation, inflammation and …

Targeting SARS-CoV-2 Main Protease (MPro) with Kinase Inhibitors: A Promising Approach for Discovering Antiviral and Anti-Inflammatory Molecules against SARS …

DB Anton, J Galvez Bulhões Pedreira… - Journal of Chemical …, 2023 - ACS Publications
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus infected over 688
million people worldwide, causing public health concern and approximately 6.8 million …

[HTML][HTML] Large-Scale Biomedical Relation Extraction Across Diverse Relation Types: Model Development and Usability Study on COVID-19

Z Zhang, M Fang, R Wu, H Zong, H Huang… - Journal of Medical …, 2023 - jmir.org
Background Biomedical relation extraction (RE) is of great importance for researchers to
conduct systematic biomedical studies. It not only helps knowledge mining, such as …

Targeting Human Proteins for Antiviral Drug Discovery and Repurposing Efforts: A Focus on Protein Kinases

R Hajjo, DA Sabbah, OH Abusara, R Kharmah… - Viruses, 2023 - mdpi.com
Despite the great technological and medical advances in fighting viral diseases, new
therapies for most of them are still lacking, and existing antivirals suffer from major limitations …

[HTML][HTML] Tetrabromobisphenol A effects on differentiating mouse embryonic stem cells reveals unexpected impact on immune system

A Tribondeau, LM Sachs, N Buisine - Frontiers in Genetics, 2022 - frontiersin.org
Tetrabromobisphenol A (TBBPA) is a potent flame retardant used in numerous appliances
and a major pollutant in households and ecosystems. In vertebrates, it was shown to affect …

Novel 4-chloro-N-phenyl Benzamide Derivatives as p38α Mitogen-activated Protein Kinase Inhibitors for Treating Cancer, COVID-19, and Other Diseases.

SK De - Recent Patents on Anti-Cancer Drug Discovery, 2022 - europepmc.org
The present disclosure relates to p38α mitogen-activated protein kinase inhibitors,
pharmaceutical compositions thereof, and the use of the p38α mitogen-activated protein …